Polit v. Janssen Pharmaceuticals, Inc. et al
| David L. Polit |
| Janssen Pharmaceuticals, Inc., Teva Branded Pharmaceutical Products R&D, TEVA PHARMACEUTICALS USA INC, JOHNSON & JOHNSON and JOHNSON & JOHNSON, INC. |
| ELMIRON (PENTOSAN POLYSULFATE SODIUM) PRODUCTS LIABILITY LITIGATION |
| 2:2021cv04487 |
| March 9, 2021 |
| US District Court for the District of New Jersey |
| Edward S Kiel |
| Brian R Martinotti |
| Personal Injury: Health Care/Pharmaceutical Personal Injury Product Liability |
| 28 U.S.C. § 1332 |
| Both |
Docket Report
RSS Track this Docket
This docket was last retrieved on April 22, 2021. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 13 NOTICE of Appearance by THOMAS GENE MCINTOSH on behalf of Teva Branded Pharmaceutical Products R&D (MCINTOSH, THOMAS) |
| Filing 12 NOTICE of Appearance by MICHAEL CHARLES ZOGBY on behalf of Janssen Pharmaceuticals, Inc. (ZOGBY, MICHAEL) |
| Filing 11 Clerk's Notice to Counsel. (gh, ) |
| Filing 10 Certified Copy of Transfer Order and docket received, Case transferred in from District of Louisiana Eastern; Case Number 2:21-cv-00367. Original file certified copy of transfer order and docket sheet received. |
| Member Case Transferred in on 3/8/21 from the Eastern District of Louisiana 2:21-cv-00367 for MDL 2973 ELMIRON (PENTOSAN POLYSULFATE SODIUM) PRODUCTS LIABILITY LITIGATION (gh, ) |
| This case is part of MDL2973. Parties are expected to review and abide by all prior orders entered in this MDL, which can be found #Here (gh, ) |
| Judge Brian R. Martinotti and Magistrate Judge Edward S. Kiel added. (gh, ) |
Filing 9
Order of MDL Transfer to District of New Jersey-Newark Division. MDL case number is 2973. Electronic file, certified copy of transfer order, and docket sheet sent. (Attachments: #1 Request Letter, #2 Transmittal Letter)(am)
|
| Filing 8 Notice of Conditional Transfer Order from MDL Panel regarding MDL 2973. (am) |
|
Filing 7
TEXT ORDER (No PDF Document Attached) granting #6 Motion for Extension of Time to Answer re #1 Notice of Removal, as to Janssen Pharmaceuticals, Inc. answer due 3/19/2021; Teva Branded Pharmaceutical Products R&D answer due 3/19/2021; Teva Pharmaceuticals USA, Inc. answer due 3/19/2021. Signed by Judge Jane Triche Milazzo on 2/25/21. (ecm)
|
| Filing 6 EXPARTE/CONSENT MOTION for Extension of Time to Answer re #1 Notice of Removal,, by Janssen Pharmaceuticals, Inc.. (Attachments: #1 Proposed Order)(Coco-Ewing, Celeste) |
| Filing 5 Statement of Corporate Disclosure by Janssen Pharmaceuticals, Inc. identifying Corporate Parent Johnson & Johnson for Janssen Pharmaceuticals, Inc. (Coco-Ewing, Celeste) |
|
Filing 4
ORDER OF RECUSAL. Judge Lance M Africk recused. Case reassigned to Judge Jane Triche Milazzo. Signed by Judge Lance M Africk on 2/22/2021.(cwa)
|
| Filing 3 Initial Case Assignment to Judge Lance M Africk and Magistrate Judge Michael North. (go) |
| Filing 2 Notice of Compliance by Janssen Pharmaceuticals, Inc. re #1 Notice of Removal. (Coco-Ewing, Celeste) Modified text on 2/22/2021 (cwa). |
| Filing 1 NOTICE OF REMOVAL from 24th Judicial District Court, Parish of Jefferson, case number 814-024 (Filing fee $402 receipt number ALAEDC-8742525) filed by Janssen Pharmaceuticals, Inc. (Attachments: #1 Civil Cover Sheet, #2 Exhibit A - State Court Record, #3 Exhibit B - Consent to Removal, #4 Proposed Pleading Notice to Adverse Party of Removal)Attorney Celeste R. Coco-Ewing added to party Janssen Pharmaceuticals, Inc.(pty:dft).(Coco-Ewing, Celeste) Modified text on 2/22/2021 (cwa). |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the New Jersey District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
